Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity.

• Main Authors: Jin-Hee Han (Author), Jee-Sun Cho (Author), Jessica J Y Ong (Author), Ji-Hoon Park (Author), Myat Htut Nyunt (Author), Edwin Sutanto (Author), Hidayat Trimarsanto (Author), Beyene Petros (Author), Abraham Aseffa (Author), Sisay Getachew (Author), Kanlaya Sriprawat (Author), Nicholas M Anstey (Author), Matthew J Grigg (Author), Bridget E Barber (Author), Timothy William (Author), Gao Qi (Author), Yaobao Liu (Author), Richard D Pearson (Author), Sarah Auburn (Author), Ric N Price (Author), Francois Nosten (Author), Laurent Rénia (Author), Bruce Russell (Author), Eun-Taek Han (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Plasmodium vivax is the most widespread and difficult to treat cause of human malaria. The development of vaccines against the blood stages of P. vivax remains a key objective for the control and elimination of vivax malaria. Erythrocyte binding-like (EBL) protein family members such as Duffy bindin...